Leo withdraws plans to launch OTC version of Dovonex

Leo withdraws plans to launch OTC version of Dovonex

September 20 2017 Leo Pharma has announced it will not now launch an over-the-counter version of...

Boots introduces generic levonorgestrel for EHC service

Boots introduces generic levonorgestrel for EHC service

September 4 2017 Boots has announced it is starting to make available a cheaper generic...

Which? challenges effectiveness, variety and cost of branded OTC medicines

Which? challenges effectiveness, variety and cost of branded OTC medicines

August 29 2017 Which? has published an article questioning the effectiveness of some over the...

Combination anti-oxidant, zinc and copper supplements protect against degenerative eye disorders

Combination anti-oxidant, zinc and copper supplements protect against degenerative eye disorders

August 25 2017 Using dietary supplements containing anti-oxidants, zinc and copper can help delay...

Case report concludes zinc in denture fixative caused numbness and muscle weakness

Case report concludes zinc in denture fixative caused numbness and muscle weakness

August 11 2017 Excessive use of a dental fixative containing zinc has been deemed the likely...

  • Leo withdraws plans to launch OTC version of Dovonex

    Leo withdraws plans to launch OTC version of Dovonex

    Wednesday, 20 September 2017 14:11
  • Boots introduces generic levonorgestrel for EHC service

    Boots introduces generic levonorgestrel for EHC service

    Monday, 04 September 2017 15:09
  • Which? challenges effectiveness, variety and cost of branded OTC medicines

    Which? challenges effectiveness, variety and cost of branded OTC medicines

    Tuesday, 29 August 2017 15:16
  • Combination anti-oxidant, zinc and copper supplements protect against degenerative eye disorders

    Combination anti-oxidant, zinc and copper supplements protect against degenerative eye disorders

    Friday, 25 August 2017 13:36
  • Case report concludes zinc in denture fixative caused numbness and muscle weakness

    Case report concludes zinc in denture fixative caused numbness and muscle weakness

    Monday, 14 August 2017 09:03

Umesh Modi is a chartered accountant, and Pamini Jatheeskumar is a chartered certified accountant at Silver Levene...
  Don Lavoie is alcohol programme manager at Public Health England and Gul Root is lead...
Don Lavoie is alcohol programme manager at Public Health England and Gul Root is lead pharmacist, Health and Wellbeing Directorate, Public Health England
More inWhite Papers  

a bmj logo cbAugust 25 2017

Using dietary supplements containing anti-oxidants, zinc and copper can help delay progression of macular degeneration and could be a cost-effective approach to eye care.

With the supplements being relatively inexpensive compared to drugs used to treat disorders such as ‘wet’ age-related macular degeneration, the supplements should be available on the NHS, the researchers have also proposed.

The findings are made in the British Journal of Ophthalmology. Researchers from London and the US evaluated the cost-effectiveness of certain supplements in patients with either bilateral intermediate age-related macular degeneration or unilateral neovascular age-related macular degeneration AMD (nAMD). Quality-adjusted life years (QALYs) and healthcare costs were the main outcome measures when compared to no intervention.

There was an improvement in both QALY with supplements and cost savings over the lifetime of the patient. Depending on the type of combination supplement given, they can be “both cost saving and more effective than no supplement use and should therefore be considered in public health policy.”

Reporting on the study, the BMJ Newsroom said two formulations were trialled. “Formulation 1 contained high doses of vitamins C and E, beta carotene, zinc and copper; in formulation 2, beta carotene was replaced with lutein and zeaxanthin, but the other constituents remained the same. Both formulations are commercially available.

“Their analysis showed that both formulations are cost effective for treating patients with early stage ‘wet’ AMD, but they were more cost effective for those with the condition in just one eye.”

Links:
BMJ Newsroom announcement                  
AY Lee et al. ‘Cost-effectiveness of age-related macular degeneration study supplements in the UK: combined trial and real-world outcomes data’. British Journal of Ophthalmology. August 2017                  

 

OTC News

September 21 2017 Pharmacy IT systems supplier Cegedim has announced it has commenced beta testing of Pharmacy Manager version 10.3. The new version has specific functionalities for England and...
December 7 2015 Pharmacists in Scotland have been asked to share their views on what politicians need to be made aware of ahead of the Scottish Parliament elections in 2016. The Royal Pharmaceutical Society...